# 03. Documented Research Gap

**Project:** Interpretable Small-Data ML for Predicting Pharmaceutical Response and Stability Under Long-Duration Spaceflight Conditions  
**Primary Reference:** [`docs/RESEARCH_DOCUMENT.md`](file:///d:/Space%20medicne/docs/RESEARCH_DOCUMENT.md) (Section 5)

---

## 1. Current State of the Literature
Space pharmacology is an established field with foundational experimental assays conducted on the Space Shuttle, Mir, and International Space Station (ISS). Historically, investigations (such as those by NASA Johnson Space Center, Wotring et al., Chuong et al., and Du et al.) have established empirical shelf-life evaluations for specific formulary medications.

## 2. The Specific Gaps Addressed by This Project

1. **Absence of Unified Multi-Compound ML Synthesis:**  
   Most existing spaceflight pharmaceutical studies analyze small batches of medications in isolation. There is a lack of integrative machine learning analyses combining empirical spaceflight degradation assays across diverse chemical scaffolds with standard molecular physicochemical descriptors.

2. **Pervasive Data Leakage in Small Spaceflight Studies:**  
   Computational analyses in space biosciences frequently employ naive random train/test splitting on repeated measurements from the same mission or drug, causing severe optimistic bias and overfitting.

3. **Lack of Closed-Form Interpretable Mathematical Equations:**  
   Existing space pharmacology lacks parsimonious, closed-form formulas $S_{\text{space}} = f(\text{radiation}, \text{duration}, \text{descriptors})$ derived via symbolic regression that can be inspected, interpreted, and utilized by spaceflight operational medical teams.
